Methylprednisolone Taper After Total Knee Arthroplasty: A Prospective Single-Blinded Randomized Trial.
J ArthroplastyApr 24, 2026 (epub)
Clinical ResearchOrthopedic Surgery
Ajay Premkumar, Emilio Arellano, Kevin Y Heo et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial evaluated the impact of a 6-day methylprednisolone taper on pain and opioid consumption in 69 patients undergoing total knee arthroplasty for osteoarthritis. The study found a significant reduction in nausea levels on postoperative day 1 in the methylprednisolone group, while pain scores and opioid use showed a nonsignificant trend towards improvement.
Key findings
- MPT group reported significantly decreased nausea levels on postoperative day 1 (P < 0.05).
- Mean cumulative oral morphine equivalent was 95.5 in the MPT group versus 116.9 in the control group.
- Pain scores were lower in the MPT group, but the difference was not statistically significant.
- No increased complications were observed in the MPT group.
Why it matters
The findings suggest that a short course of methylprednisolone may enhance postoperative comfort by reducing nausea, which could improve patient satisfaction and potentially influence opioid consumption patterns.